Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment



Rating:

Share or cite this content

Citations should be made in the following way:
B. Haliloglu, Y. Gokdemir, Z. Atay, S. Abali, T. Guran, F. Karakoc, R. Ersu, B. Karadag, S. Turan, A. Bereket (Istanbul, Turkey). Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM). Eur Respir J 2014; 44: Suppl. 58, 1216

Member's Comments

No comment yet.

Related content which might interest you: Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Difficulties in optimizing vitamin D levels in paediatric cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Screening colonoscopy in adults with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Lung MRI findings in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Cystic fibrosis: paediatric Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Cystic fibrosis: paediatric Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Cystic fibrosis: paediatric Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Cystic fibrosis: paediatric Source: ERS Skills Course 2016 Year: 2016 Cystic fibrosis: adult Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Cystic fibrosis: adult Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Cystic fibrosis: adult Source: ERS Skills Course 2016 Year: 2016 Cystic fibrosis: adult Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Annual change of LCI among patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 The role of CFTR/ENaC genotype in cystic fibrosis-like phenotypes Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014